Gene Query: GDNF

Dataset Description Geneva Score
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 49.84
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 39.34
Role of COP1 on MAP kinase transcriptional output in melanoma 29.37
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 24.7
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 23.71
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 22.04
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 21.79
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 21.3
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 20.14
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 19.0
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 18.26
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 18.07
Transcriptional effect of ETV1 knockdown in melanoma cells 16.95
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 16.92
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 16.81
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 15.44
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 14.08
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 13.78
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 13.68
Generation of trichogenic adipose-derived stem cells by expression of three factors 13.25
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 12.49
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 12.26
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 12.1
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 11.99
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 11.99
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 11.58
Gene expression changes in human melanoma cell lines compared to primary melanocytes 10.83
Disruption of the exocyst induces podocyte loss and dysfunction 10.14
Effect of mitochondria deficiency on senescence-associated gene expression 9.78
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 9.38
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 9.21
Gene expression profiling of KSHV-infected periodontal ligament cells 9.2
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 9.05
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 9.05
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 9.05
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 8.94
Random mono-allelic expression in MECP2-mutated cells 8.91
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 8.51
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 8.45
Differential analysis of gene regulation at transcript resolution by RNA-Seq 8.45
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 8.28
Transcriptome analysis of U87 cells upon LINC00152 knockdown 8.24
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 7.62
An acquired vulnerability of drug resistant melanoma with therapeutic potential 7.62
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 6.99
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 6.88
mRNA differential expression analysis in a human ex vivo model of chronic wounds 6.84
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 6.28
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 6.25
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 6.19
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 6.07
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 5.78
Modeling Human Cancer-induced Cachexia (Human) 5.67
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 5.63
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 5.61
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 5.6
RNA-seq melanoma 5.58
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 5.58
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 5.48
A sister of NANOG regulates genes expressed in pre-implantation human development 5.42
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 5.29
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 5.27
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 5.14
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 5.14
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 5.14
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 5.02
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 4.94
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 4.84
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 4.77
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 4.76
Proteomics identifies a marker signature of MAPKi resistance in melanoma 4.61
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 4.56
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 4.56
Ectoderm specification of H1 human embryonic stem cells 4.56
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.55
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.55
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 4.41
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 4.41
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 4.33
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 4.29
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 4.15
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 4.15
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 4.14
The Genomic Landscape of Atypical Fibroxanthoma 4.13
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 4.06
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 4.05
Analysis of transcriptional regulation by Myt1 and Myt1l 3.91
Differential gene expression in Jagged1 treated human dental pulp cells. 3.89
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 3.73
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 3.7
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 3.7
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 3.68
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 3.65
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 3.64
Identification of the role of polydom in neurofibromas 3.61
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 3.57
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 3.38
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 3.37
AR-independent prostate cancer is sustained through FGF signaling 3.32
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 3.18
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 3.15
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 3.12
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 3.09
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 3.01
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 3.01
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 3.01
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 2.95
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 2.95
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 2.95
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 2.95
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 2.86
circRNA-sequencing 2.77
RNAseq Analysis in glioblastoma cells treated with Mepazine 2.73
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 2.72
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 2.67
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 2.66
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 2.63
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 2.63
Controlling for gene expression changes in transcription factor protein networks. 2.56
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.54
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 2.5
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 2.49
RNA sequencing analysis of human embryonic stem cells and axial progenitors 2.46
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 2.45
Next Generation Sequencing of human SMA and healthy control Motor Neurons 2.44
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 2.42
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 2.42
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 2.38
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.37
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 2.37
2.34
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 2.31
Gene expression profile of human iPSC-derived nephron progenitor cells 2.27
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 2.23
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 2.2
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 2.2
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 2.18
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 2.18
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 2.17
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 2.15
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 2.12
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 2.1
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 2.1
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 2.08
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 2.08
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 2.04
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 2.04
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 2.02
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 1.98
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 1.95
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 1.95
Gene expression of thyroid cancer cell lines 1.95
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 1.94
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 1.92
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 1.92
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 1.92
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 1.92
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 1.88
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.85
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.85
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 1.84
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.83
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 1.83
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 1.83
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 1.81
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.81
Transcriptional responses of melanoma cells to BRAF inhibition 1.81
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 1.8
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 1.74
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 1.74
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 1.74
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 1.73
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 1.73
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 1.73
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 1.71
Global expression profiles in cardiac progenitor cells generated by ISX-9 1.7
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 1.7
CUREfast: Accelerating research with families 1.69
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.68
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 1.67
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.65
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 1.63
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 1.63
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 1.62
RNA-seq of cells with TET1 knockout 1.53
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 1.5
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 1.49
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 1.48
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 1.44
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 1.41
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 1.38
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 1.37
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 1.36
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 1.36
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 1.36
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 1.36
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 1.35
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 1.35
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.35
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 1.35
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 1.34
HEXIM1 is induced by DHODH inhibition to suppress melanoma 1.34
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 1.32
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 1.32
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 1.3
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 1.29
Differential gene expression of human melanoma cells [RNA-seq] 1.29
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 1.28
X-Ray induced DNA-Hydroxymethylation changes 1.26
UBC9 knockdown in bladder cancer T24 cell lines 1.26
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 1.25
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 1.25
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 1.25
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 1.25
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 1.24
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.21
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.2
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.2
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 1.2
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 1.18
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 1.18
Generating Patterned Kidney Organoids for Studying Development and Diseases 1.18
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 1.17
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 1.16
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 1.15
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 1.14
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.14
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.14
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.13
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.13
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 1.13
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.13
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 1.11
RNA-seq of MCF10A cells and CAF 1.11
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 1.08
EWS-Fli and LNC regulated genes in comparison to GFP samples 1.07
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 1.07
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.07
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 1.06
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 1.06
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 1.06
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 1.06
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 1.05
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 1.03
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.03
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 1.03
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 1.0
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 1.0
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 1.0
Metabolism as an early predictor of DPSCs aging 0.99
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 0.98
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.98
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.98
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 0.96
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.96
RNA sequencing of BT142 and TS603 cell lines 0.95
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 0.95
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 0.95
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 0.95
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 0.94
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 0.94
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 0.94
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 0.93
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 0.9
Redifferentiation of expanded human islet β cells by inhibition of ARX 0.9
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.9
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 0.9
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.89
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 0.88
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 0.87
Investigation about fibroblasts of different origins in culture 0.87
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 0.87
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 0.86
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 0.84
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.84
Reassessment of Exosome Composition 0.84
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.84
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 0.83
Neurofibroma 0.83
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.83
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.83
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 0.81
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 0.79
RNA-seq of young and quiescent MRC-5 human fibroblasts 0.79
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 0.77
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.77
RNA-seq of human fibroblasts after irradiation 0.75
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 0.75
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 0.75
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 0.75
DRB/GRO-Seq -/+ UV 0.74
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 0.73
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.73
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 0.73
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.72
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.71
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 0.7
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.69
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.69
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 0.69
Nonpregnant and term pregnant human myometrial tissues 0.69
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 0.69
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 0.69
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 0.69
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 0.69
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 0.69
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 0.68
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 0.68
Modeling Familial Cancer with iPSC Approaches 0.68
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 0.67
T47D RNA-seq and ChrRNA-seq data 0.67
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 0.67
Metastasis in triple-negative breast cancer 0.66
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.66
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 0.66
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 0.65
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 0.64
Transcriptome analysis of BAP1 knockout and restoration 0.64
Identification of HOXB13 target genes responsive to BET inhibitors 0.63
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 0.63
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 0.62
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.62
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.62
High-efficiency RNA-based reprogramming of human primary fibroblasts 0.61
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 0.61
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 0.61
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.6
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.6
RNA Seq of Alagille liver biopsies 0.59
Alagille_Nodder 0.59
Gene expression profile in breast cancer cell lines using RNA sequencing 0.59
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 0.59
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 0.59
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 0.58
The role of FAM46C in myeloma cells 0.58
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 0.58
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 0.58
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 0.57
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 0.57
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 0.56
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 0.56
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 0.56
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.56
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.55
Nucleoporin-mediated regulation of cell identity genes 0.55
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 0.55
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 0.55
RNA-seq analysis of the human fetal kidney. 0.54
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 0.54
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 0.54
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 0.54
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 0.54
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.54
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.53
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.53
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 0.53
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.53
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 0.53
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 0.52
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.52
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  0.52
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 0.51
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.51
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 0.51
The DNA methylation landscape of human melanoma 0.5
The DNA methylation landscape of human melanoma [RNA-Seq] 0.5
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.5
DIGIT regulates endoderm differentiation of human embryonic stem cells 0.5
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 0.49
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 0.49
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 0.49
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.49
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 0.48
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.47
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 0.47
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 0.47
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.47
Patient-derived xenograft platform for metastatic melanoma 0.47
Transcriptomic profile of human embryonic renal corpuscles 0.47
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 0.46
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 0.46
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 0.46
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 0.46
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 0.46
Gene expression patterns define the hepatocyte-like cells derived by different strategies 0.46
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 0.45
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 0.45
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 0.45
mRNA-Seq profiling of human developing kidney 0.45
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.44
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 0.44
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 0.43
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 0.43
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 0.43
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.43
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 0.42
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.42
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.42
RNA-seq of SCLC PDX models treated with EP 0.42
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.42
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 0.41
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 0.41
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 0.41
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 0.39
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 0.39
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 0.39
The MEF2B Regulatory Network 0.38
The MEF2B Regulatory Network - RNA-seq data 0.38
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 0.38
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.38
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 0.37
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.36
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.35
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 0.34
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.34
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 0.34
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 0.33
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 0.33
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 0.33
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 0.33
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 0.33
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 0.33
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.32
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.32
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.32
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.32
CHD1 regulates cell fate determination by activation of differentiation-induced genes 0.32
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.31
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.31
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.31
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.29
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.29
6mer seed toxicity in viral microRNAs 0.28
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 0.28
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.26
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.26
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.26
6mer seed toxicity in tumour suppressive microRNAs 0.25
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.25
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.25
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 0.25
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.24
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.23
Identification of differentially expressed genes between senescence and senescence bypass cells 0.23
RNA-sequencing of healthy human skeletal myocytes 0.22
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.22
IL-33 activates tumor stroma to promote intestinal polyposis 0.22
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 0.21
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 0.21
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 0.21
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.21
mRNA sequencing of oropharyngeal cancer cell lines 0.2
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.19
Gene expression analysis of human hepatocellular cancers 0.18
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.18
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 0.17
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.17
Transcriptome analysis of human lung epithelial cells 0.16
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.16
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 0.16
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 0.15
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 0.15
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 0.15
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.14
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.14
Hepatic transcriptome of pediatric hepatoblastoma. 0.13
The role of m6A/m-RNA methylation in stress response regulation 0.13
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.13
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 0.12
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.12
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.11
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 0.1
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.1
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 0.1
RNA-seq in endometrial stromal tumors 0.08
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.08
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.08
Expression profiling of converted and control dermal BJ fibroblasts 0.08
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 0.08
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.07
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.07
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 0.07
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.06
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.06
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.06
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.06
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 0.05
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.05
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 0.05
RNA editing in nascent RNA affects pre-mRNA splicing 0.04
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.04
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.03
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.03
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.02
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 0.02
KSDM1b Role in Ewing Sarcoma 0.02
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.02
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.01
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 0.0
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation